PL2134742T3 - Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt - Google Patents

Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt

Info

Publication number
PL2134742T3
PL2134742T3 PL08730629T PL08730629T PL2134742T3 PL 2134742 T3 PL2134742 T3 PL 2134742T3 PL 08730629 T PL08730629 T PL 08730629T PL 08730629 T PL08730629 T PL 08730629T PL 2134742 T3 PL2134742 T3 PL 2134742T3
Authority
PL
Poland
Prior art keywords
treating
immunogenic compositions
preventing animal
animal infections
infections
Prior art date
Application number
PL08730629T
Other languages
English (en)
Inventor
Michael A Gill
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL2134742T3 publication Critical patent/PL2134742T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL08730629T 2007-02-27 2008-02-25 Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt PL2134742T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90358607P 2007-02-27 2007-02-27
PCT/US2008/054867 WO2008106393A2 (en) 2007-02-27 2008-02-25 Immunogenic compositions and methods for treating and preventing animal infections
EP08730629A EP2134742B1 (en) 2007-02-27 2008-02-25 Immunogenic compositions for treating and preventing animal infections

Publications (1)

Publication Number Publication Date
PL2134742T3 true PL2134742T3 (pl) 2012-10-31

Family

ID=39714016

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08730629T PL2134742T3 (pl) 2007-02-27 2008-02-25 Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt

Country Status (11)

Country Link
US (1) US20100233204A1 (pl)
EP (1) EP2134742B1 (pl)
JP (1) JP5470052B2 (pl)
AU (1) AU2008219380B2 (pl)
CY (1) CY1113061T1 (pl)
DK (1) DK2134742T3 (pl)
ES (1) ES2389121T3 (pl)
PL (1) PL2134742T3 (pl)
PT (1) PT2134742E (pl)
SI (1) SI2134742T1 (pl)
WO (1) WO2008106393A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0819938B1 (pt) * 2007-12-21 2019-02-26 Zoetis Services Llc Vacinas com bactérias e com emulsão tratadas com calor preparadas a partir de tais bactérias tratadas com calor
CN109735504B (zh) * 2018-12-20 2021-04-16 兆丰华生物科技(南京)有限公司 犬瘟热病毒弱毒疫苗株及其应用
WO2021211749A1 (en) * 2020-04-14 2021-10-21 The Regents Of The University Of California Multi-epitope pan-coronavirus vaccine compositions
US12558415B2 (en) 2020-04-14 2026-02-24 The Regents Of The University Of California Broad-spectrum multi-antigen pan-coronavirus vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658757A (en) * 1993-03-31 1997-08-19 The Regents Of The University Of California Cloned leptospira outer membrane protein
WO2004032599A2 (en) * 2002-10-10 2004-04-22 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira
HRP20050660A2 (en) * 2003-01-29 2006-02-28 Pfizer Products Inc. Canine vaccines against bordetella bronchiseptica
US20050089533A1 (en) 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica

Also Published As

Publication number Publication date
AU2008219380B2 (en) 2014-01-30
EP2134742B1 (en) 2012-06-27
PT2134742E (pt) 2012-09-06
DK2134742T3 (da) 2012-08-06
AU2008219380A1 (en) 2008-09-04
JP5470052B2 (ja) 2014-04-16
WO2008106393A3 (en) 2008-12-04
US20100233204A1 (en) 2010-09-16
EP2134742A2 (en) 2009-12-23
ES2389121T3 (es) 2012-10-23
JP2010518875A (ja) 2010-06-03
CY1113061T1 (el) 2016-04-13
WO2008106393A2 (en) 2008-09-04
SI2134742T1 (sl) 2012-09-28

Similar Documents

Publication Publication Date Title
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
EP2076116A4 (en) COMPOSITIONS, METHODS, AND DEVICES FOR TREATING HEPATIC DISEASES
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
GB2471806B (en) Compositions and methods for treating viral infections
IL202015A0 (en) Methods and compositions for treating skin conditions
ZA201203709B (en) Immunogenic compositions and methods
GB0718446D0 (en) Compositions and methods for the treatment of infection
ZA200907492B (en) Compositions for targeted imaging and therapy
ZA200900140B (en) Methods and compositions for treating biofilms
BRPI1007929A2 (pt) "métodos e composições para o tratamento de neovascularização".
IL210097A0 (en) Compositions and methods for treating unfluenza
IL209336A0 (en) Compositions for treating hyperproliferative diseases and uses thereof
HUP0700369D0 (en) Pharmaceutical compositions and method for treating schizofrenia
ZA200806361B (en) Methods and compositions for treating feline hyperthyroidism
IL196411A0 (en) Anti-cocaine compositions and treatment
GB0718918D0 (en) Compositions and methods for treating skin conditions
LT2111855T (lt) Antibakteriės kompozicijos, skirtos viršutinių ir apatinių kvėpavimo takų infekcijų gydymui
IL196638A0 (en) Methods and compositions for treating disease
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
PL2134742T3 (pl) Kompozycje immunogenne do leczenia i profilaktyki zakażeń zwierząt
PH12012500528A1 (en) Compositions and methods for treating bacterial infections using caftaroline
GB0714500D0 (en) composition and treatment
IL211282A0 (en) Compositions and use thereof for treating s. pneumoniae infection
IL211283A0 (en) Compositions and use thereof for treating s. pneumoniae infection
ZA200807049B (en) Compositions and methods for treating collagen-mediated diseases